| GSE57872 | GSM1396244 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_CSC8_G06 | gliomasphere CSC8 | cell line: CSC8; cell type: Gliomasphere Cell Line |
| GSE64016 | GSM1562572 | Illumina HiSeq 2500 | Homo sapiens | H1_Exp3.264 | single H1 hESC | cell type: human embryonic stem cells; passages: 30-35; treatment: not sorted |
| GSE64016 | GSM1562837 | Illumina HiSeq 2500 | Homo sapiens | G2_Exp1.059 | single H1-Fucci cell sorted from G2-M phase of the cell cycle only | cell type: human embryonic stem cells; passages: 35-40; treatment: FACS sorted |
| GSE66357 | GSM1620361 | Illumina NextSeq 500 | Homo sapiens | PS034_R2_0_319 | U87 human glioma cells | cell type: U87 human glioma cells |
| GSE67835 | GSM1657905 | Illumina NextSeq 500 | Homo sapiens | healthy cortex cell 35 | hippocampus hybrid | tissue: hippocampus; cell type: hybrid; age: postnatal 54 years; c1 chip id: 1772078218; experiment_sample_name: AB_S8 |
| GSE67835 | GSM1658161 | Illumina NextSeq 500 | Homo sapiens | healthy cortex cell 291 | cortex hybrid | tissue: cortex; cell type: hybrid; age: postnatal 21 years; c1 chip id: nochipID8; experiment_sample_name: AB_S7 |
| GSE67980 | GSM1660153 | AB 5500xl Genetic Analyzer | Homo sapiens | Pr9.3.7 | lineage-confirmed PCa CTC CRPC enzalutamide-naive (Group A) | donor: Pr9; donor type: CRPC; enzalutamide: enzalutamide-naive (Group A) |
| GSE69405 | GSM1702701 | Illumina HiSeq 2500 | Homo sapiens | LC-PT-45-Re_SC40 | PDX, LC-PT-45-Re | cell type: PDX |
| GSE70580 | GSM1810656 | Illumina HiSeq 2000 | Homo sapiens | T75_P2_A5_ILC3 | Donor T75-tonsil innate lymphoid cell (ILC3) | tonsil donor: Donor T75; facs gating: ILC3; cell type: tonsil Innate lymphoid cells |
| GSE70580 | GSM1810912 | Illumina HiSeq 2000 | Homo sapiens | T86_P1_F4_ILC3 | Donor T86-tonsil innate lymphoid cell (ILC3) | tonsil donor: Donor T86; facs gating: ILC3; cell type: tonsil Innate lymphoid cells |
